Cutting-edge new research “Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” indicates that the core personalized medicine market will be worth over $149 billion by 2020 with a CAGR of 8.74%. This market is made up of companion diagnostics and targeted therapeutics and is dominated by oncology, cardiovascular and infectious disease targeted treatment and diagnostics. The report has already been procured by 21 of the top 25 Pharma companies globally. This newly published edition, is a revolutionary insight into the vertical growing market of personalized healthcare globally.
Complete Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 report of 393 pages is available at http://www.reportsnreports.com/reports/472795-personalized-medicine-targeted-therapeutics-and-companion-diagnostic-market-to-2019-strategic-analysis-of-industry-trends-technologies-participants-and-environment.html.
The analysts forecasts that the total personalised targeted therapeutic market, for all indications, will grow at a CAGR of 6.47% over the next five years. Strong vertical growth in the companion diagnostic segment however will see a CAGR of 23.71% to 2020, mainly coming from oncology, cardiovascular and infectious disease (HIV/HCV) tests. Advancing technologies within the liquid biopsy market is also driving the market and will see strategic growth over the next five years with a CAGR of 20.6%. The two segments of the liquid biopsy market are tumor cell enrichment products and tumor cell detection technologies.
Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics are more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine reduces the frequency of adverse drug reactions and therefore has a dramatic impact on health economics. Developmental and diagnostic companies benefit from lower discovery and commercialization costs and more specific market subtypes.
This new report gives a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 360 tables & figures over 393 pages. The personalized medicine market is presented as follows: By Company (e.g., QIAGEN, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD); By Segment (Targeted therapeutics, Companion Diagnostics); By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy); By Therapy (Cancer, Cardiovascular, Infectious Disease)
A wealth of financial data & business strategy information is provided including: Company Financials, Sales & Revenue Figures; Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies; Business Model Strategies for Providers. Provider Systems and Academic Medical Centres; Business Model Strategies for Payers & Governments; Private and Public Funding and Personalized Medicine Reimbursement; Revisions to Current Payment Systems and Intellectual Property; How to Gain Market Penetration in the EU; Cost-effectiveness and Business Value of Personalized Medicine; Consumer genomics and POC market; Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations); Comprehensive Account of Company Product Portfolios & Kits.
ORDER a copy of this report at (Prices start at US$3800 for a Single User PDF) – http://www.reportsnreports.com/purchase.aspx?name=472795. Alternatively Get a DISCOUNT on the Report at http://www.reportsnreports.com/contacts/discount.aspx?name=472795.
SWOT, Economic & Regulatory Environment specifics include: Key Strengths, Weaknesses and Threats Influencing Leading Player Position within the Market; Technologies Driving the Market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing); Top Fastest Growing Market Segments and Emerging Opportunities; Top Pharmaceutical Companies within the IPM by Market Share and Revenue; Comprehensive Product Portfolios, R&D Activity and Pipeline Therapeutics; M&A Activity and Future Strategies of Top Personalized Medicine Pharmacos; Personalized Medicine Regulation (UK, Germany, France, Spain, Italy); CE-Marked Personalized Medicine/Diagnostic Tests; FDA Advances in Personalized Medicine Regulation
This report highlights a number of significant players and influential company’s and gives details of their operations, products, financials and business strategy: 23andMe, Abbott Laboratories, Abbott Molecular Inc., Admera Health (GENEWIZ), Affymetrix, Agendia, Alere, Amgen, Astex Pharmaceuticals, AstraZeneca, Atossa Genetics, Becton Dickenson, bioMerieux, BristolMyersSquibb, Cancer Genetics, Celera (Quest Diagnostics), Celldex Therapeutics, Claritas Genomics, CuraGen, Danaher (Leica Biosystems), deCode Genetics (Amgen), Foundation Medicine, EDP Biotech, Eli Lilly, ELDA BioTech, Eisai, Genelex, GlaxoSmithKline, Human Longevity Inc (Cypher Genomics), HalioDx, Ikonisys, Illumina, InterGenetics, Johnson & Johnson, LabCorp, Life Technologies, Merck, MDxHealth, MolecularMD Corporation, Monogram Biosciences, Myriad, Nodality, Novartis MDx, Orion Genomics, Oxford BioTherapeutics, NanoString Technologies, Pfizer, Qiagen, Roche Molecular Diagnostics, Sanofi, SensiGen, Siemens Healthcare Diagnostics, Takeda, Thermo Fisher Scientific, Transgenomic, Ventana (Roche), Vermillion (Ciphergen), Vertex Pharmaceuticals
Updates on the personalized medicine, targeted therapeutic and companion diagnostic space have been included in this latest edition to include cutting edge material from international conferences, workshops and symposia.
This report will tell you if the companies mentioned are: Strong, competitive players; Pooling their resources for specific growth and therapeutic areas; Investing strategically in R&D; Have a history of strategic M&A activity
What you will gain:
- An in-depth understanding of the global personalized medicine market and it’s environment
- Current market facts, figures and product lines of key players in the industry
- Emerging trends in key markets such as the US, UK, Germany and France
- Knowledge of how the personalized medicine market will integrate into the global healthcare market
- Technical insights into new generation sequencing technologies and ultra-high throughput sequencing
- Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
- FDA approved pharmacogenetic tests and recognized biomarkers
- Information on key government and regulatory policies
- Strategies on how to adapt and restructure current business models to this industry
This report tackles key concerns to the personalized medicine market such as:
- Lack of regulatory policy and legislation in the US and Europe
- Reimbursement schemes and payers concerns
- Transition of investigational diagnostic assays and therapeutics to clinical practice
- Direct to consumer (DTC) test kits and implications for the public
Benefits of Investing in our Cutting-Edge Reports:
- Clients receive complementary content* with mid-level and enterprise wide licences
- Post-sale complementary consultation with senior expert analyst is included
- Use of tables and figures in your own reports and presentations is permitted
- Each report provides straight-talking strategic analysis & sector intelligence
- All reports are updated each quarter to give you the most up-to-date information
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
P: + 1 888 391 5441